Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Liver Cirrhosis

Free Subscription Articles published in Gut Retrieve available abstracts of 51 articles: HTML format

Single Articles

July 2008
1. COLTART I , Austin M, Shawcross DL
   Response to "MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation".
   Gut. 2008;57:1024-5.
   PubMed     Related articles   
   
   
   May 2008
2. BERAZA N , Malato Y, Vander Borght S, Liedtke C, et al
   Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis.
   Gut. 2008;57:655-63.
   PubMed     Related articles    Abstract available
   
   
   March 2008
3. TARGHER G , Zoppini G, Muggeo M
   Differential relationships between basal and post-load insulin resistance indices and hepatic fibrosis in chronic hepatitis C and in non-alcoholic fatty liver disease.
   Gut. 2008;57:426.
   PubMed     Related articles   
   
   
   
4. DE MINICIS S , Candelaresi C, Marzioni M, Saccomano S, et al
   Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo.
   Gut. 2008;57:352-64.
   PubMed     Related articles    Abstract available
   
   
   February 2008
5. BAMBHA K , Kim WR, Pedersen RA, Bida JP, et al
   Predictors of Rebleeding and Mortality Following Acute Variceal Hemorrhage in Patients with Cirrhosis.
   Gut. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. MOLLER S , Henriksen JH
   Cardiovascular complications of cirrhosis.
   Gut. 2008;57:268-78.
   PubMed     Related articles    Abstract available
   
   
   January 2008
7. RIGAMONTI C , Donato MF, Fraquelli M, Agnelli F, et al
   Transient elastography predicts fibrosis progression in patients with recurrent hepatitis c after liver transplantation.
   Gut. 2008;.
   PubMed     Related articles    Abstract available
   
   
   December 2007
8. JANG JH , Moritz W, Graf R, Clavien PA, et al
   Preconditioning with death ligands FasL & TNF-a protects the cirrhotic mouse liver against ischemic injury.
   Gut. 2007;.
   PubMed     Related articles    Abstract available   Free Full Text
   
   
   September 2007
9. YONEDA M , Fujita K, Inamori M, Nakajima A, et al
   Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD).
   Gut. 2007;56:1330-1.
   PubMed     Related articles   
   
   
   August 2007
10. ALEMPIJEVIC T , Kovacevic N, Testa R
    Right liver lobe diameter:albumin ratio: a new non-invasive parameter for prediction of oesophageal varices in patients with liver cirrhosis (preliminary report) * Author's reply.
    Gut. 2007;56:1166-7.
    PubMed     Related articles   
    
    
    
11. ZEIN CO , McCullough AJ, Jones DE, Newton JL, et al
    Association between fatigue and decreased survival in primary biliary cirrhosis * Authors' reply.
    Gut. 2007;56:1165-6.
    PubMed     Related articles   
    
    
    July 2007
12. WEISSENBORN K , Ahl B, Fischer-Wasels D, van den Hoff J, et al
    Correlations between MRS alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
13. JONES DE
    Pathogenesis of Primary Biliary Cirrhosis.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
14. HOLT AP , Adams DH
    Complex roles of cyclo-oxygenase 2 in hepatitis.
    Gut. 2007;56:903-4.
    PubMed     Related articles   
    
    
    
15. FRAQUELLI M , Rigamonti C, Casazza G, Conte D, et al
    Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease.
    Gut. 2007;56:968-73.
    PubMed     Related articles    Abstract available
    
    
    June 2007
16. PAGLIANO P , Carannante N, Gramiccia M, Ascione T, et al
    Visceral leishmaniasis causes fever and decompensation in patients with cirrhosis.
    Gut. 2007;56:893-4.
    PubMed     Related articles   
    
    
    
17. LEE SS , Liu H
    Cardiovascular determinants of survival in cirrhosis.
    Gut. 2007;56:746-8.
    PubMed     Related articles   
    
    
    May 2007
18. HUANG JF , Hsieh MY, Dai CY, Hou NJ, et al
    The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies.
    Gut. 2007;56:736-7.
    PubMed     Related articles   
    
    
    
19. REDDY Y , Twaij Z, Mullins PD
    Familial liver disease.
    Gut. 2007;56:676.
    PubMed     Related articles   
    
    
    
20. THURSZ M
    Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.
    Gut. 2007;56:613-614.
    PubMed     Related articles   
    
    
    
21. KINOSHITA K , Iimuro Y, Otogawa K, Saika S, et al
    Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats.
    Gut. 2007;56:706-14.
    PubMed     Related articles    Abstract available
    
    
    April 2007
22. LONDONO MC , Cardenas A, Guevara M, de Las Heras D, et al
    Meld score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    March 2007
23. SVEGLIATI-BARONI G , Bugianesi E, Bousheral T, Ridolfi F, et al
    Post-load insulin resistance is an independent predictor of hepatic fibrosis in Virus C Chronic Hepatitis and in Nonalcoholic Fatty Liver Disease.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
24. SALERNO F , Gerbes A, Gines P, Wong F, et al
    Diagnosis, prevention and treatment of the hepatorenal syndrome in cirrhosis. A consensus workshop of the international ascites club.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
25. NEAL K , Irving WL
    Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. ASSY N , Hussein O, Abassi Z
    Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis.
    Gut. 2007;56:443-4.
    PubMed     Related articles   
    
    
    February 2007
27. SANSOE G , Wong F
    Natriuretic and Aquaretic Effects of I.V. Infused Calcium in Pre-ascitic Human Cirrhosis: Pathophysiological and Clinical Implications.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
28. INAGAKI Y , Okazaki I
    Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis.
    Gut. 2007;56:284-92.
    PubMed     Related articles   
    
    
    
29. CUCCHETTI A , Vivarelli M, Heaton ND, Phillips S, et al
    Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease.
    Gut. 2007;56:253-8.
    PubMed     Related articles    Abstract available
    
    
    December 2006
30. CHOLONGITAS E , Quaglia A, Samonakis D, Senzolo M, et al
    Transjugular liver biopsy: how good is it for accurate histological interpretation?
    Gut. 2006;55:1789-94.
    PubMed     Related articles    Abstract available
    
    
    November 2006
31. CAZZANIGA M , Salerno F, Pagnozzi G, Dionigi E, et al
    Diastolic dysfunction is associated with poor survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
32. SARTORI M , Andorno S, Pagliarulo M, Rigamonti C, et al
    Heterozygous {beta} -globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis c.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
33. COBBOLD JF , Wylezinska M, Cunningham C, Crossey ME, et al
    Non-invasive evaluation of hepatic fibrosis using magnetic resonance and ultrasound techniques * Author's reply.
    Gut. 2006;55:1670.
    PubMed     Related articles   
    
    
    
34. ARMENDARIZ-BORUNDA J , Islas-Carbajal MC, Meza-Garcia E, Rincon AR, et al
    A pilot study in patients with established advanced liver fibrosis using pirfenidone.
    Gut. 2006;55:1663-5.
    PubMed     Related articles   
    
    
    
35. GUHA IN , Parkes J, Roderick PR, Harris S, et al
    Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.
    Gut. 2006;55:1650-60.
    PubMed     Related articles    Abstract available
    
    
    October 2006
36. MOORE KP , Aithal GP
    Guidelines on the management of ascites in cirrhosis.
    Gut. 2006;55 Suppl 6:vi1-vi12.
    PubMed     Related articles       Free Full Text
    
    
    September 2006
37. CODES L , Asselah T, Cazals-Hatem D, Tubach F, et al
    Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of menopause and steatosis and the potential benefit of hormone replacement therapy.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
38. KINOSHITA K , Iimuro Y, Fujimoto J, Inagaki Y, et al
    Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre-LoxP system to antagonise hepatic fibrosis.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
39. ANGUS PW
    Role of endothelin in systemic and portal resistance in cirrhosis.
    Gut. 2006;55:1230-2.
    PubMed     Related articles   
    
    
    August 2006
40. KAWADA N
    Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease.
    Gut. 2006;55:1073-4.
    PubMed     Related articles   
    
    
    July 2006
41. ALBILLOS A , Banares R, Gonzalez M, Catalina MV, et al
    The extent of the collateral circulation influences the postprandial increase in portal pressure in cirrhotic patient.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
42. MORENO-OTERO R , Trapero-Marugan M, Mendoza J
    Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase.
    Gut. 2006;55:1055-6.
    PubMed     Related articles   
    
    
    
43. MARRA F
    Thiazolidinediones and hepatic fibrosis: don't wait too long.
    Gut. 2006;55:917-9.
    PubMed     Related articles   
    
    
    June 2006
44. CURRO G , Cucinotta E
    Percutaneous gall bladder aspiration as an alternative to laparoscopic cholecystectomy in Child-Pugh C cirrhotic patients with acute cholecystitis.
    Gut. 2006;55:898-9.
    PubMed     Related articles   
    
    
    May 2006
45. HUO TI , Wu JC, Lee SD, Yuen MF, et al
    Do baseline ALT levels predict complications of chronic hepatitis B? * Authors' reply.
    Gut. 2006;55:745-6.
    PubMed     Related articles   
    
    
    April 2006
46. ALLOCCA M , Crosignani A, Gritti A, Ghilardi G, et al
    Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
47. STANDISH RA , Cholongitas E, Dhillon A, Burroughs AK, et al
    An appraisal of the histopathological assessment of liver fibrosis.
    Gut. 2006;55:569-78.
    PubMed     Related articles   
    
    
    March 2006
48. EBRAHIMKHANI MR , Kiani S, Oakley F, Kendall T, et al
    Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    February 2006
49. LECLERCQ IA , Sempoux C, Starkel P, Horsmans YW, et al
    Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    January 2006
50. NOVO E , Marra F, Zamara E, Valfre di Bonzo L, et al
    Overexpression of bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    October 2005
51. CAGNIN A , Taylor-Robinson SD, Forton DM, Banati RB, et al
    In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy.
    Gut 2005;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: